Romosozumab(anti-sclerostin) | Read Reviews & Product Use Citations

Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug, that simultaneously increases bone formation and decreases bone resorption.

Purity & Quality Control

Batch: A205001 Purity: 98% Protein concentration: 4.1mg/ml Endotoxin Level: <1 EU/mg

98

Biological Activity

Description	Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug, that simultaneously increases bone formation and decreases bone resorption.

References
Geusens P, et al. Expert Opin Biol Ther. 2022 Nov 28.

References

Geusens P, et al. Expert Opin Biol Ther. 2022 Nov 28.

Product Details

CAS No.	909395-70-6
Molecular Weight	150 kDa
Isotype	human IGg2, κ
Application	Romosozumab(anti-sclerostin)
Purification	Protein G
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field